Status:
TERMINATED
Central Mechanisms in Speech Motor Control Studied With H215O PET
Lead Sponsor:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Communication Disorder
Healthy
Eligibility:
All Genders
18-85 years
Brief Summary
Positron Emission Tomography (PET) is a technique used to investigate the functional activity of the brain. The PET technique allows doctors to study the normal biochemical and metabolic processes of ...
Detailed Description
Objective The primary objective of this protocol is to use multimodal neuroimaging combining complementary electrophysiological and hemodynamic methods to characterize brain-language relationships in...
Eligibility Criteria
- INCLUSION CRITERIA FOR ALL SUBJECTS:
Ages 18 to 85.
Ability to provide informed consent.
Must be a Native English speaker by age 2
SPECIFIC INCLUSION CRITERIA FOR SELECTED GROUPS OF HEALTHY VOLUNTEERS:
Have had training and experience in creative writing
Have had training and experience in vocal or instrumental music
Have had training and experience in visual arts
SPECIFIC INCLUSION CRITERIA FOR POST-STROKE APHASIA SUBJECTS:
Had sensorimotor and language deficits following ischemic infarcts.
Had stroke at least two weeks ago.
SPECIFIC INCLUSION CRITERIA FOR TRAUMATIC BRAIN INJURY SUBJECTS:
Diagnosis of TBI
At least one month post-injury
SPECIFIC INCLUSION CRITERIA FOR STUTTERING SUBJECTS:
History of developmental stuttering with symptoms of dysfluency presenting before the age of 13
If recovered, history documented by school or medical records.
SPECIFIC INCLUSION CRITERIA FOR EPILEPSY SUBJECTS:
Ages 18 to 55 years.
Failure of seizures to respond to adequate therapy with at least two standard antiepileptic drugs.
Willingness to be considered for surgery
Fluency in English. Non-native speakers may be included if their fluency is equivalent to that of a native speaker.
Must have localization-related epilepsy
Must be currently enrolled in Protocol 08-N-0161 to participate in this study
EXCLUSION CRITERIA FOR ALL SUBJECTS:
Past or present major medical or psychiatric illnesses (DSM-IV criteria) except Post Traumatic Stress Disorder (PTSD) in TBI subjects an anxiety disorder in stuttering subjects
Significant abnormalities on the general physical examination unrelated to the stroke or TBI
Unable to undergo MRI studies due to pacemakers, aneurysm clips, cochlear implants, shrapnel fragments or a significant history of exposure to small metallic objects which might have become lodged in the tissues of the head or neck or who require hearing aids.
Subjects who are pregnant are excluded from the PET and MRI tests in this study.
Subjects who are lactating are excluded from the PET tests.
Subjects who have or are found to have significant visual agnosia.
Subjects who cannot provide informed consent.
SPECIFIC EXCLUSION CRITERIA FOR POST-STROKE APHASIA SUBJECTS:
More than two prior strokes
Concurrent diagnoses of neurodegenerative disorders or vascular dementia
Comprehension Aphasia Quotient (AQ) of less than 4 on the Western Aphasia Battery (WAB)
SPECIFIC EXCLUSION CRITERIA FOR TRAUMATIC BRAIN INJURY SUBJECTS:
For military subjects: Positive screen for Acinetobacter baumannii-calcoaceticus complex (ABC) infection or colonization
Severe cognitive impairments as evidenced by scores of less than 7 on the Rancho Los Amigos Scale of Cognitive Functioning and/or less than 76 on the Galveston Orientation and Amnesia Test.
For all subjects: Comprehension AQ of less than 4 on the WAB
A diagnosis of PTSD, which is almost always found in TBI subjects recruited from the military, will not disquality TBI subjects from participation.
SPECIFIC EXCLUSION CRITERIA FOR STUTTERING SUBJECTS:
Structural abnormalities on standard clinical (MPRAGE, T2-weighted) MRI scans studies
A diagnosis of anxiety dirorder will not disqualify stuttering subjects from participation
SPECIFIC EXCLUSION CRITERIA FOR EPILEPSY SUBJECTS:
Claustrophobia or anxiety disorders that could be exacerbated by the MRI Scanner
Subjects with neurological disorders, in addition to epilepsy such as, stroke, Parkinson s disease), or who have psychiatric diagnoses (, such as, obsessive-compulsive disorder)
Patients on Phenobarbital or chronic Benxodiazepines
Key Trial Info
Start Date :
April 28 1992
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 6 2016
Estimated Enrollment :
1163 Patients enrolled
Trial Details
Trial ID
NCT00001308
Start Date
April 28 1992
End Date
October 6 2016
Last Update
December 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892